Skip to main content
Clinical Trials/NCT06225765
NCT06225765
Recruiting
Not Applicable

A Prospective Trial Comparing Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) and Conventional Open Thyroidectomy

Tseung Kwan O Hospital, Hong Kong1 site in 1 country40 target enrollmentJuly 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Benign Thyroid Nodule
Sponsor
Tseung Kwan O Hospital, Hong Kong
Enrollment
40
Locations
1
Primary Endpoint
Voice quality of life
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

To determine if transoral endoscopic thyroidectomy vestibular approach (TOETVA) is a safe and effective procedure compared to traditional open thyroidectomy. Surgical outcomes, patients' satisfaction, voice and swallowing outcomes will be assessed.

Detailed Description

This is a prospective case control study involving a total 40 patients, with 20 stratified into the test group receiving surgery under transoral endoscopic thyroidectomy vestibular approach (TOETVA) and 20 patients to the control group under traditional open approach. Subjects will be assigned to either group without randomization. Patients satisfactory score, voice and swallowing quality of life outcomes will be assessed using Voice Handicap Index (VHI) and MD Anderson Dysphagia Inventory (MDADI) outcomes. Surgical outcomes, for instance, lower lip numbness, skin injury, operative time, blood loss, vocal cord paralysis, temporary and permanent hypoparathyroidism will be assessed.

Registry
clinicaltrials.gov
Start Date
July 1, 2024
End Date
September 30, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Tseung Kwan O Hospital, Hong Kong
Responsible Party
Principal Investigator
Principal Investigator

YEUNG WING CHI ZENON

Consultant, Department of Otorhinolaryngology, Head and Neck Surgery

Tseung Kwan O Hospital, Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Benign thyroid nodule less than 4cm
  • Suspicious malignant thyroid nodule less than 2cm, suitable for transoral endoscopic surgery

Exclusion Criteria

  • Patients under 18 years old
  • Contraindication to general anaesthesia
  • Vulnerable population (e.g. Cognitive impairment, pregnant)
  • Previous anterior neck surgery
  • Previous radiotherapy at the head and neck region
  • Malignant thyroid nodule \> 2cm
  • Presence of another malignancy, lateral neck, or distant metastasis
  • Retrosternal goitre
  • Cervical spine disease precluding extension of the neck
  • Obesity with BMI \> 35kg/m2

Outcomes

Primary Outcomes

Voice quality of life

Time Frame: Post-operative 6 months

Voice Handicap Index - 30 assessing functional, physical and emotional scales

Swallowing quality of life

Time Frame: Post-operative 6 months

MD Anderson dysphagia inventory (MDADI)

Complication rate and types

Time Frame: Post-operative 6 months

Lower lip numbness, vocal cord paralysis, permanent hypoparathyroidism

Patient's satisfactory score

Time Frame: Post-operative 6 months

Visual analogue scale 0-10

Post-operative pain

Time Frame: Post-operative 6 months

Visual analogue scale 0-10

Secondary Outcomes

  • Rate of conversion to open surgery(Intra-operatively)
  • Operative time(Intra-operatively)
  • Inpatient stay(An average of 0-2 days after the operation)
  • Blood loss(Intra-operatively)

Study Sites (1)

Loading locations...

Similar Trials